Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma | Nature Communications
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study - The Lancet Oncology
CD40: Targeting Co-Stimulatory Pathways for Cancer Immunotherapy
CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma - Journal of Hepatology
Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
Anti-CD40 agonist antibodies may be the way to go for bladder cancer
Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity | PNAS
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo- controlled, proof-of-concept study - The Lancet Rheumatology
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology
Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement - ScienceDirect
Anti-CD40 clinical trials* against pancreatic cancer | Download Table
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint - ScienceDirect
CD40 therapy and surgery: a potential immunologic partnership. - Abstract - Europe PMC
CD40
With the High Potential in Cancer Immunotherapy, CD40 Is Triggering Attention - Cusabio
Anti-CD40 agonistic antibody eradicates tumor and induces transient... | Download Scientific Diagram
CDX-1140, A Novel Agonist CD40 Antibody with Potent Anti-lymphoma Activity
![PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7cb235318895039cd45eb055391de568e99105c1/2-Table1-1.png "PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar")
PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar
Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment - Van Audenaerde - 2020 - Clinical & Translational Immunology - Wiley Online Library
Next-IO™ Anti-CD40 Therapeutic Monoclonal Antibody Program - Creative Biolabs
InVivoMAb anti-mouse CD40 | Bio X Cell
List of clinically used agonistic CD40 antibodies | Download Scientific Diagram
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy - Parker Institute for Cancer Immunotherapy
